Wednesday, July 31, 2019

Recent Trends in Oncology


FDA has approved darolutamide for treatment of nonmetastatic castration-resistant prostate cancer in men. Explore more about cancer here: http://bit.ly/2K4sRl4
#CancerConferences

No comments:

Post a Comment